Veritas Asset Management LLP Pfizer Inc Transaction History

Veritas Asset Management LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $7.78 Million - $9.89 Million	-232,400 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $6.23 Million - $8.9 Million	-230,400 Reduced 49.78%	232,400 $7.59 Million
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $4.64 Million - $6.02 Million	-142,800 Reduced 23.58%	462,800 $16.6 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $32.8 Million - $37.4 Million	-853,800 Reduced 58.5%	605,600 $26.4 Million
Q3 2018 Oct 26, 2018	BUY	$34.47 - $41.81 $1.83 Million - $2.22 Million	53,000 Added 3.77%	1,459,400 $64.3 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $6.22 Million - $6.6 Million	-187,000 Reduced 11.74%	1,406,400 $50.9 Million
Q2 2017 Aug 08, 2017	BUY	N/A	1,593,400	1,593,400 $53.5 Million

3,257

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Veritas Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Veritas Asset Management LLP with notifications on news.